Atul Pande Receives Stock Award at Sio Gene Therapies Inc (SIOX) — SEC Form 4, Apr 19, 2021
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Atul Pande CIK 0001643071 |
Director
|
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.47 | 2021-04-15 | A - Award/Grant | 42,000 A | $0.00 | 2031-04-14 | 42,000 Common Stock | Direct |
Footnotes (1)
- F1
- 100% of this option will vest on April 15, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan. Show more
Related filings at Sio Gene Therapies Inc
Institutional Holders
13F holders · Jun 30, 2023
1
institutional managers reporting a position
Largest by reported value
- Macquarie Group Ltd $26K
Other insiders at Sio Gene Therapies Inc
GET /v1/forms/4/0001636050-21-000048
API docs
View Original SEC Filing